Bortezomib pharmacokinetics in tumor response and peripheral neuropathy in multiple myeloma patients receiving bortezomib-containing therapy.
Lee SE et al. Anticancer Drugs. 2017 Apr 20. doi: 10.1097/CAD.0000000000000506. [Epub ahead of print].

Paraneoplastic acute disseminated encephalomyelitis associated with multiple myeloma.
Law LY et al. Mult Scler Relat Disord. 2017 Apr;13:21-24. doi: 10.1016/j.msard.2017.01.013.

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study.
Quach H et al. Cancer Chemother Pharmacol. 2017 Apr 19. doi: 10.1007/s00280-017-3287-8. [Epub ahead of print].

Anorectal involvement in a patient with multiple myeloma.
Russo P et al. BMJ Case Rep. 2017 Apr 18;2017. pii: bcr-2017-219658. doi: 10.1136/bcr-2017-219658.

Back pain in the emergency department: Pathological fracture following spinal manipulation.
Skappak C et al. CJEM. 2017 Apr 17:1-6. doi: 10.1017/cem.2017.19. [Epub ahead of print].

Diagnosis and management of neuropathies associated with plasma cell dyscrasias.
Rosenbaum E et al. Hematol Oncol. 2017 Apr 10. doi: 10.1002/hon.2417. [Epub ahead of print].

Clinical disorders responsible for plasma hyperviscosity and skin complications.
Caimi G et al. Eur J Intern Med. 2017 Apr 5. pii: S0953-6205(17)30131-0. doi: 10.1016/j.ejim.2017.04.001. [Epub ahead of print].

Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
Noto R et al. BMC Nephrol. 2017 Apr 6;18(1):127. doi: 10.1186/s12882-017-0524-7.

Bisphosphonate-Related Osteonecrosis and Metastasis Within the Same Site of the Jaw: Expected for Multiple Myeloma, But Unusual for Breast Cancer.
Altundag K et al. J Oral Maxillofac Surg. 2017 Apr 4. pii: S0278-2391(17)30258-6. doi: 10.1016/j.joms.2017.02.030. [Epub ahead of print].

Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Sezer O et al. Br J Haematol. 2017 Apr 6. doi: 10.1111/bjh.14637. [Epub ahead of print].

Epidemiological characteristics of primary spinal osseous tumors in Eastern China.
Zhou Z et al. World J Surg Oncol. 2017 Apr 4;15(1):73. doi: 10.1186/s12957-017-1136-1.

Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone.
Velasco-Tamariz V et al. Int Wound J. 2017 Mar 29. doi: 10.1111/iwj.12746. [Epub ahead of print].